composition or insulin resistance in WT mice. These data suggest that As3mt KO is associated with an adverse metabolic phenotype that is characterized by obesity and insulin resistance, and that the extent of the impairment depends on sex and exposure to iAs, including exposure to iAs from mouse diet.
Introduction
Arsenic (+3 oxidation state) methyltransferase (AS3MT) is the key enzyme in the metabolism of inorganic (i) arsenic (As) (Lin et al. 2001) . It catalyzes the S-adenosylmethioninedependent methylation of iAs yielding methyl-As (MAs), dimethyl-As (DMAs) and trimethyl-As (TMAs) metabolites that contain either trivalent As III or pentavalent arsenic As V (Thomas et al. 2007 ). The methylation of iAs is essential for clearance of As from the body (Drobná et al. 2009 ) and thus plays a detoxification function. However, the methylated trivalent arsenicals (MAs III and DMAs III ) are more toxic and biologically active than iAs (Stýblo et al. 2000 (Stýblo et al. , 2002 . Both population and laboratory studies show that impaired methylation of iAs is associated with an increased acute iAs toxicity or with an increased susceptibility to adverse effects associated with chronic exposure to iAs (Antonelli et al. 2014; Tseng 2009 ). In 2009, a strain of C57BL/6 mice knocked out (KO) for As3mt was established by Thomas and coworkers (Drobná et al. 2009 ) to provide a laboratory model for in vivo studies examining the role of iAs methylation in adverse effects of iAs exposure. Several previous studies have described the pattern of iAs metabolism in As3mt-KO mice and confirmed that very little methylated arsenicals are Abstract Susceptibility to toxic effects of inorganic arsenic (iAs) depends, in part, on efficiency of iAs methylation by arsenic (+3 oxidation state) methyltransferase (AS3MT). As3mt-knockout (KO) mice that cannot efficiently methylate iAs represent an ideal model to study the association between iAs metabolism and adverse effects of iAs exposure, including effects on metabolic phenotype. The present study compared measures of glucose metabolism, insulin resistance and obesity in male and female wild-type (WT) and As3mt-KO mice during a 24-week exposure to iAs in drinking water (0.1 or 1 mg As/L) and in control WT and As3mt-KO mice drinking deionized water. Results show that effects of iAs exposure on fasting blood glucose (FBG) and glucose tolerance in either WT or KO mice were relatively minor and varied during the exposure. The major effects were associated with As3mt KO. Both male and female control KO mice had higher body mass with higher percentage of fat than their respective WT controls. However, only male KO mice were insulin resistant as indicated by high FBG, and high plasma insulin at fasting state and 15 min after glucose challenge. Exposure to iAs increased fat mass and insulin resistance in both male and female KO mice, but had no significant effects on body produced after exposure to iAs (Chen et al. 2011; Drobná et al. 2009; Hughes et al. 2010) . However, little is known about the susceptibility of these mice to iAs toxicity. Few studies published to date have focused mainly on effects of iAs exposure in urinary bladder of As3mt-KO mice Dodmane et al. 2013 Dodmane et al. , 2014 Yokohira et al. 2010 Yokohira et al. , 2011 . We have recently compared urine and plasma metabolomes of wild-type (WT) and As3mt-KO mice and found that As3mt KO is associated with significant shifts in levels of metabolites in pathways of amino acid, carbohydrate and lipid metabolism (Huang et al. 2016a) . We have also found plasma triglycerides levels to be higher in male As3mt-KO as compared to male WT mice after exposure to iAs. Taken together, our findings suggest that As3mt KO has a broader impact on major metabolic pathways and may be associated with an increased susceptibility to metabolic diseases in iAsexposed mice.
The International Agency for Research of Cancer (IARC) has classified iAs as a human carcinogen (IARC 2004) . Based on the IARC review, chronic exposures to iAs in drinking water have been linked to an increased risk of skin, bladder, lung and possibly liver cancer. DNA damage by reactive oxygen species generated in response to iAs exposure and inhibition of DNA repair mechanisms by iAs or its metabolites have been suggested as potential mechanisms underlying the carcinogenic effects of iAs (Kligerman et al. 2010; Wnek et al. 2011) . iAs and its trivalent methylated metabolites, MAs III and DMAs
III
, are also potent endocrine disruptors that affect several pathways and mechanisms regulating hormone production or function, including glucose stimulated insulin secretion by pancreas (Díaz-Villaseñor et al. 2006; Douillet et al. 2013; Fu et al. 2010) or insulin signaling and insulin-dependent glucose uptake in adipocytes (Walton et al. 2004; Paul et al. 2007a ). Inhibition of these mechanisms is thought to be responsible for an impaired glucose homeostasis and increased risk of diabetes that have been reported in both population studies and in laboratory studies using mice or rats exposed to iAs (Maull et al. 2012) . Human exposures to iAs have also been linked to adverse metabolic phenotypes characterized by dysglycemia, dyslipidemia, inflammation and high blood pressure, the established risk factors for diabetes and cardiovascular disease (Abhyankar et al. 2012; Chen et al. 2012; Maull et al. 2012; Moon et al. 2012; States et al. 2009; Wang et al. 2007; Wu et al. 2012) . Notably, the capacity to methylate iAs (as characterized by profiles of iAs and the methylated metabolites in urine) has been consistently shown to affect the risk of cancers and cardiometabolic disease in populations chronically exposed to iAs (Ahsan et al. 2007; Chen et al. 2003 Chen et al. , 2009 Del Razo et al. 2011; Huang et al. 2008; Kim et al. 2013; Li et al. 2013; Maull et al. 2012; Mendez et al. 2016; Nizam et al. 2013; Yu et al. 2000) .
The goal of the present study was to examine the role of iAs methylation as a potential modulator of the effects of iAs exposure on metabolic phenotype by comparing measures of glucose metabolism, insulin resistance, and obesity in WT and As3mt-KO C57BL/6 mice exposed to iAs with respective unexposed controls. Results suggest that As3mt KO results in increased fat accumulation, insulin resistance, and impaired glucose metabolism. The extent of these effects depends on sex of mice and on the level of exposure.
Materials and methods

Mice and treatment
All procedures involving mice were approved by the University of North Carolina (UNC) Institutional Animal Care and Use Committee. Male and female C57BL/6J WT mice were obtained from Jackson Laboratories (Bar Harbor, ME, USA) and let to acclimatize at the UNC Animal Facilities for 1 week. Male and female As3mt-KO mice on a C57BL/6 background (Drobná, et al. 2009 ) were bred at the UNC Animal Facilities. Both WT and As3mt-KO mice were housed under controlled conditions with 12-h light/ dark cycle at 22 ± 1 °C and 50 ± 10% relative humidity (3-5 mice per cage) and with unlimited access to pelleted 2920X Teklad rodent chow (Envigo, Madison, WI, USA). All mice were 21 weeks old at the beginning of the study when they were randomly assigned to treatment groups with 10-14 animals per group. Both WT and As3mt-KO mice drank for 24 weeks (ad libitum) either deionized water or deionized water containing sodium arsenite (AsNaO 2 , ≥99% pure; Sigma-Aldrich, St. Louis, MO, USA) at final concentrations of 0.1 or 1.0 mg As/L (i.e., 0.1 or 1 ppm). Water with sodium arsenite was prepared weekly to minimize oxidation of iAs III to iAs V . Food and water consumption and body weight were monitored in all treatment groups weekly.
Metabolic phenotyping
The study design is summarized in Supplemental Figure 1 . Fasting blood glucose (FBG) was measured at week 1, 8, 12 and 24 of iAs exposure. Mice were fasted for 6 h and FBG levels were measured in blood collected from tail cuts using OneTouch Ultra 2 glucometer (LifeScan, Milpitas, CA, USA). In addition to measurements of FBG, a glucose tolerance test was administered to all mice at week 1 and 8. Here, fasted mice were injected i.p. with 2 g/ kg b.w. of d-glucose (Sigma-Aldrich) dissolved in Dulbecco's phosphate-buffered saline (Mediatech, Manassas, VA, USA) and glucose levels were measured in blood collected by tail bleeds 15, 30, 60 and 120 min post-injection.
To quantify glucose tolerance, area under the curve (AUC) was determined for a plot of blood glucose (mg/dL) versus time (min) using Prism 5 (GraphPad, La Jolla, CA, USA). To examine insulin resistance, plasma insulin was measured in fasted mice (week 12 and 24) and 15 min after i.p. injection of d-glucose (2 g/kg b.w.) (week 12); plasma was isolated from blood collected by tail bleeds. The levels of insulin in plasma were determined by ELISA (EMD Millipore, St Charles, MO, USA) following the manufacturer's protocol. Body composition (lean and fat mass) was determined at week 19 by magnetic resonance imaging (MRI) using EchoMRI three-in-one Composition Analyzer and Labmaster version 3.2.2 software (Echo Medical Systems, Houston, TX, USA).
Sample collection at sacrifice
After 24 weeks, all mice were fasted for 6 h and spot urine samples were collected by placing a glass capillary tube next to the urethral meatus and applying gentle abdominal pressure. Mice were then killed by cervical dislocation. Half of the mice in each treatment group were injected i.p. with insulin (2 U/kg b.w.) exactly 10 min prior to kill. Samples of liver (right medial lobes) were collected during the dissection, snapped frozen in liquid nitrogen, and stored along with urine samples at −80 °C.
Assessment of insulin-activated signal transduction in the liver
The levels of total and phosphorylated protein kinase B (Akt) were determined in livers of mice injected with insulin prior to kill as previously described (Paul et al. 2007a ). Briefly, liver tissue was homogenized in a lysis buffer containing protease and phosphatase inhibitors. The homogenate was sonicated for 10 s and then centrifugated at 16,000g for 10 min at 4 °C. The protein concentration of the supernatants was determined by Bicinchoninic Assay (Pierce Thermo Fisher, Waltham, MA, USA). Proteins were resolved by SDS-PAGE and transferred to PVDF membranes for immunoblot analysis. The phosphorylated Akt (p-Akt/Ser 473) and total Akt were detected using monoclonal antibodies from Cell Signaling (Danvers, MA, USA). The immunoblots were quantified using a Versadoc imaging system (Biorad, Hercules, CA, USA). Each blot contained one liver supernate from each treatment group. One unique liver supernate was used as an internal standard on every immunoblot. The ratio of p-Akt/Akt was calculated for each liver supernate and expressed as a percentage of the p-Akt/Akt ratio of the internal standard for the given blot. This approach controlled for blot-to-blot variations and allowed comparison of the p-Akt/Akt values across the treatment groups.
Speciation analysis of arsenic
Arsenic species in samples of urine and in phosphoric acid-digested liver homogenates were measured by hydride generation atomic absorption spectrometry coupled with a cryotrap (HG-CT-AAS) as previously described Currier et al. 2011) . Calibration curves for quantification of As species were generated using aqueous solutions of pentavalent As standards, including sodium arsenate (≥99% pure) from Sigma-Aldrich, and methylarsonic and dimethylarsinic acids (98% pure) from Chem Service (West Chester, PA, USA). All samples and standards were treated with 2% cysteine for 60 min prior to analysis to convert all pentavalent arsenicals to trivalency ). As applied in this study, the HG-CT-AAS analysis determined concentrations of total iAs (i.e., iAs III + iAs V ), total MAs (MAs III + MAs V ) and total DMAs (DMAs III + DMAs V ); no TMAs was detected in either urines or livers. HG-CT-AAS was also used to determine the content and speciation of As in 3 lots of the 2920X Teklad mouse diet that were fed to the mice during the 24 weeks of the study. Here, 4-6 pellets from each lot were powdered and microwave-digested in ultrapure phosphoric acid (J. T. Baker, Phillipsburg, NJ, USA); the digestates were treated with 2% cysteine before analysis.
Statistical analysis
ANOVA with Fisher's least significant differences posttest for multiple comparisons were used to evaluate differences between treatment groups in the measures of glucose and insulin metabolism, in p-Akt/Akt ratio, in body composition and mass, and in the concentrations of total As and As species in urines and livers. Data were expressed as mean ± standard error (SE); p values <0.05 were considered statistically significant. All statistical analyses were performed using StatView 5.0 (SAS Institute Inc., Cary, NC, USA).
Results
Food and water consumption, and body mass
Exposure to iAs had no significant effects on the amount of food or water consumed by either WT or As3mt-KO mice (Suppl. Figure 2) . However, male WT mice consumed significantly more food and water than WT females or male or female As3mt-KO mice (p < 0.05). There were no significant differences in either food or water consumption between male and female KO mice.
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The As3mt-KO mice, males and females, had significantly greater body mass than their WT counterparts already at the beginning of the study (p < 0.0001) and this difference remained statistically significant at week 24 (p < 0.0001) (Suppl. Figure 3 ). In addition, as a result of the random assignment to the treatment groups, male and female KO mice in the 0.1 ppm group were heavier than their KO counterparts in the control and 1 ppm groups at the start of the exposure (p ≤ 0.013), and remained heavier throughout the study.
All mice gained weight between week 0 and week 24 (Suppl. Figure 4) , but the average absolute and relative weight gains differed between the treatment groups. Control male WT mice gained more weight than control WT females. Exposure to 1 ppm iAs decreased the weight gain in WT males and increased it in WT as well as KO females. Female KO mice in control and 1 ppm groups gained more weight than WT females in the respective treatment groups. In contrast, exposure to iAs had no significant effects on weight gain of male KO mice. There were no significant differences in weight gains between KO males and KO females regardless of treatment.
Metabolic phenotypes
Phenotyping was carried out throughout the study. The time points for individual tests were selected to reduce stress associated with animal handling and with invasive procedures involving injections and blood collections, and also to allow enough time for healing and recovery.
Fasting glycemia
FBG was measured at three time points during the study (week 1, 8 and 12) and at kill (week 24). In general, control and iAs-treated male As3mt-KO mice had the highest FBG levels (Fig. 1) , although the differences between this and the other groups were not always statistically significant. The extent and directions of the effects of iAs exposure on FBG varied throughout the study. At week 1, male WT and male KO mice exposed to 0.1 and 1 ppm As had higher FBG than the respective controls, but there were no statistically significant differences in FPG of iAs-treated and control WT or KO females. In contrast, male KO and female WT mice exposed to 0.1 ppm As for 8 weeks had lower FBG than mice in the respective control groups and in groups exposed to 1 ppm As; iAs exposure had little effects on FPG in male WT and female KO mice. At week 12, the only group affected by iAs exposure were male WT mice drinking water with 0.1 ppm As-FBG was significantly higher in this group as compared to the male WT control and 1 ppm groups. No statistically significant effects of iAs exposure were found at week 24.
Glucose tolerance
An i.p. glucose tolerance test (IP-GTT) was administered at week 1 and 8; AUC was calculated for each mouse. At week 1, male As3mt-KO mice were less glucose tolerant than male and female mice in other groups as indicated by higher AUC values (Fig. 2) . iAs exposure had no significant effects on AUC in male WT and KO or in female WT mice; however, exposure to 0.1 ppm As increased AUC in female KO mice. There were little or no differences in AUC values between WT and to As3mt KO mice at week 8. At this time point, male WT and male KO mice were less glucose tolerant than female mice in the respective groups. Exposure to iAs increased AUC in male KO mice, but only at 0.1 ppm level, and had no effects on AUC in other groups.
Insulin resistance
Fasting plasma insulin (FPI) levels determined at week 12 were significantly higher in male KO mice as compared to KO females and to WT males or females (Fig. 3a) . There were no significant differences in FPI between male and female WT and female KO mice regardless of treatment; the difference between KO females in the control and 0.1 ppm groups was only marginally significant (p = 0.052). Male KO mice exposed to 0.1 ppm As had significantly higher FPI than KO males in the control and 1 ppm groups. FPI levels in female KO mice were significantly lower than those in male KO mice. Results of FPI analysis at week 24 were generally consistent with those at week 12; however, here exposure to 0.1 ppm increased FPI in both male and female KO mice. The response of pancreas to glucose challenge was tested only at week 12. The blood glucose levels 15 min after i.p. injection of glucose Fig. 2 I. p. glucose tolerance test (IP-GTT) in male and female wildtype (WT) and As3mt-knockout (KO) mice after 1 and 8 weeks of exposure to 0, 0.1 or 1 ppm As in drinking water. Area under the curve (AUC) was calculated for a plot of blood glucose versus time (mean +SE, N = 10-14). p < 0.05 for the following comparisons: d, 0.1 versus 0 ppm or 1 versus 0 ppm for mice of the same sex and genotype; g, KO versus WT mice of the same sex and at the same exposure level; s, females versus males of the same genotype and at the same exposure level Fig. 3 Fasting plasma insulin in male and female wild-type (WT) and As3mt-knockout (KO) mice after 12 and 24 weeks of exposure to 0, 0.1 or 1 ppm As in drinking water (mean +SE, N = 10-14). p < 0.05 for the following comparisons: d, 0.1 versus 0 ppm or 1 versus 0 ppm for mice of the same sex and genotype; d*, 1 versus 0.1 ppm for mice of the same sex and genotype; g, KO versus WT mice of the same sex and at the same exposure level; s, females versus males of the same genotype and at the same exposure level were consistently lower in female KO as compared to female WT mice, regardless of treatment (Fig. 4a) . Male KO mice exposed to 0.1 ppm As had higher 15-min blood glucose than control male KO. The differences in 15-min plasma insulin resembled those found in fasting plasmainsulin concentrations were higher in plasma of male and female KO mice as compared to WT males and females, respectively (Fig. 4b ). There were also differences between KO male and KO female mice-insulin levels were significantly higher in the male groups. No statistically significant effects of iAs exposure were found; the lowest p value of 0.071 was found for the difference between plasma insulin levels of control KO female mice and KO females exposed to 0.1 ppm As.
To further characterize insulin resistance, we measured total Akt and p-Akt in livers of mice injected with insulin prior to kill at week 24 (Suppl. Figure 5) . The highest p-Akt/Akt ratios were found in livers of WT female mice and the lowest in livers of KO males. Because of substantial variations, very few differences between the treatment groups were statistically significant. However, the average p-Akt/Akt ratio correlated negatively with average FPI level measured at kill: R 2 = 0.51, p < 0.01 (Fig. 5) .
Body composition
The MRI analysis carried out at week 19 showed that fat and lean mass differed significantly between WT and KO mice-the bodies of male and female KO mice contained significantly more fat that those of male and female WT mice (Fig. 6a) . In addition, male KO mice had less lean mass than WT males. Fat represented 31 and 27% of body mass of control male and female KO mice, respectively, as compared to 11% for control male and 12.5% for control female WT mice (Fig. 6b) . Male KO mice exposed to 0.1 ppm As had more fat than males in the KO control or 1 ppm group, but %fat was not significantly different. Female KO mice exposed to either 0.1 or 1 ppm had more fat and %fat than KO control females. iAs exposure had no significant effects on fat mass or %fat of WT male and female mice.
Arsenic species in urine and liver
Urine and livers for As analysis were collected at kill (week 24). Total As concentration in urine (iAs + MAs + DMAs) of both WT and KO mice increased with the level of iAs exposure in a dose-dependent manner (Fig. 7a ). DMAs were the major As species in urines of WT mice, followed by iAs and MAs. Urines of KO mice contained Linear correlation between the average p-Akt/Akt ratio in the liver and the average concentration of insulin in fasting plasma of male (M) and female (F) wild-type (WT) and As3mt-knockout (KO) mice after 24-week exposure to 0, 0.1 or 1 ppm As in drinking water almost exclusively iAs; only traces of MAs and DMAs were detected. Total As levels were significantly lower in urine of male KO mice exposed to 1 ppm As than in urine of male WT mice at the same exposure level; no other differences due to KO or sex were found within the exposure groups. More pronounced differences were found in As content of the livers (Fig. 7b) . As3mt KO was associated with significantly higher levels of total As in all treatment groups. Sex was also an important factor-livers of female KO mice exposed to 0.1 or 1 ppm As contained more total As than livers of the respective male KO mice. In contrast, there were no significant differences in total As levels between WT male and female mice; no significant effects of iAs exposure were found. Similar to urine, livers of KO mice contained almost exclusively iAs. Notably, urine and livers of control WT and KO mice that drank only deionized water contained relatively high levels of As, suggesting that these mice were exposed to As from diet.
Arsenic concentration in the diet
To determine whether diet was an additional source of As exposure, we analyzed three lots of 2920X Teklad chow that were used in the course of the study. The concentrations of As in these lots ranged from 110 to 136 µg As/kg (i.e., 0.11 and 0.136 ppm); iAs was the only As species found with traces of MAs detected in one of the lots. 
Discussion
Environmental exposures to iAs have been shown to increase the risk of metabolic disease, including diabetes and cardiovascular disease (Abhyankar et al. 2012; Chen et al. 2012; Maull et al. 2012; Moon et al. 2012; States et al. 2009; Wang et al. 2007; Wu et al. 2012 ). However, with only a limited number of laboratory studies carried out to date, mechanisms underlying the metabolic effects of iAs are poorly understood. Overwhelming evidence suggests that the capacity to methylate iAs plays a major role in susceptibility to these effects (Ahsan et al. 2007; Chen et al. 2003 Chen et al. , 2009 Del Razo et al. 2011; Huang et al. 2008; Kim et al. 2013; Li et al. 2013; Maull et al. 2012; Mendez et al. 2016; Nizam et al. 2013; Yu et al. 2000) . The As3mt-KO mouse strain was created to facilitate laboratory research focusing on the role of iAs methylation in the adverse effects of iAs exposure. Basic characteristics of iAs metabolism in As3mt-KO mice have been previously published. These mice are not able to effectively methylate iAs and retain large amounts of iAs in tissues; the clearance of iAs from the body is slow when compared to WT mice (Drobná et al. 2009; Hughes et al. 2010) . Little is known about other metabolic pathways that could be affected by As3mt KO. Although the only known function of As3mt is the methylation of iAs, it is possible that this enzyme is involved in other methylation reactions. We have recently compared global metabolomic profiles of As3mt-KO and WT mice exposed to iAs and of the unexposed WT and KO controls (Huang et al. 2016a) . We found significant differences in both plasma and urinary metabolomes. These differences were sex-dependent and pointed to an altered carbohydrate and lipid metabolism, suggesting that As3mt-KO mice may be more susceptible to developing an adverse metabolic phenotype. The goal of the present study was to investigate and characterize this phenotype. We have previously reported that exposure of male WT C57BL/6 mice to 50 ppm As (as arsenite) in drinking water, alone (Paul et al. 2007b) or combined with high-fat diet (Paul et al. 2011) , resulted in impaired glucose tolerance and in a failure of pancreas to secrete insulin in response to glucose challenge. In contrast, the present study using much lower levels of iAs exposure (0.1 and 1 ppm) found only minor effects on FBG or glucose tolerance in either WT and KO mice, and these effects varied over the time of the study (Figs. 1, 2) . The lack of a more pronounced effect on glucose metabolism after exposure to 0.1 and 1 ppm suggests that mice, which metabolize iAs more efficiently than humans (Vahter 1994) , may have to be exposed to higher levels of iAs to reproduce the metabolic effects of iAs reported in population studies. It is also possible that the mice were adapted to iAs because they were exposed to relatively high levels of iAs in the diet prior to (and during) the exposure to iAs in drinking water. In fact, the differences in metabolic phenotypes of WT and KO mice in the control groups (not exposed to iAs in drinking water) could be, at least in part, due to the exposure to iAs from the diet and due to the limited capacity of KO mice to metabolize this iAs, resulting in its accumulation in the metabolically active tissues, including liver (Fig. 7) . Notably, exposure to As from diet has not been examined or taken into account in most published studies on the effects of iAs exposure in laboratory rodents, thus confusing the reported results and their interpretation. Results of our study highlight the need to monitor and account for the background exposure to iAs from animal diets used in laboratory studies, especially in studies examining effects of very low (ppb levels) exposures to iAs from other sources, including drinking water.
In spite of the variations, male KO mice, both control and iAs-treated, appeared to have higher FBG and higher AUC values than males and females in other treatment groups (Figs. 1, 2 ). Male KO mice had also significantly higher FPI and plasma insulin 15 min after glucose challenge (Figs. 3, 4) . Taken together, these findings are indicative of insulin resistance. Insulin resistance is usually associated with obesity and can progress to type 2 diabetes if followed by β-cell dysfunction and failure of β-cells to secrete sufficient amounts of insulin in response to high blood glucose (Ferrannini 1998; Weyer et al. 2001) . In this study, male KO mice accumulated more fat and had higher % body fat than either WT males or WT females (Fig. 6) . Notably, KO males became obese while consuming less food than lean WT males (Suppl. Figure 2b) , suggesting a major difference in energy expenditure. The KO female mice accumulated almost as much fat as KO males and there was no difference in % body fat among these two groups. Despite being as obese as KO males and having higher levels of As in the liver (Fig. 7) , the KO females were not as insulin resistant as indicated by significantly lower FPI and 15-min plasma insulin levels (Figs. 3, 4) . Thus, the fat accumulation or iAs disposition alone cannot explain the differences in insulin resistance between KO male and KO female mice. It is possible that As3mt KO affects in a sex-dependent manner expression of genes regulating carbohydrate, lipid and/or energy metabolism, and that a modified expression of these genes is responsible for or contributes to the adverse metabolic phenotype of KO mice. A comprehensive analysis of transcriptomes of male and female WT and As3mt-KO mice as well as comparison of energy metabolism and expenditure between the two mouse strains and the sexes would help to answer this question.
The exposure to iAs in drinking water, particularly exposure to 0.1 ppm As, appeared to increase fat mass or %fat, and FPI in KO male and female mice, but had no effects on fat accumulation or plasma insulin in WT mice (Figs. 3, 4, 6 ).
In general, the effects of iAs exposure were minor as compared to the major effects of As3mt KO and sex. These findings are consistent with results of our metabolomic study that found sex to play a major role in the metabolomic responses to As3mt KO in C57BL/6 mice (Huang et al. 2016a ). The KO-related shifts in plasma and urinary metabolomes differed significantly between males and females, while iAs exposure in drinking water (1 ppm) had only minor effects. Metabolism of lipids, specifically phosphatidylcholines, was among the most affected pathways in As3mt-KO mice (Huang et al. 2016b) . Notably, phosphatidylcholines make up 60-80% of the phospholipid component of plasma lipoproteins (Cole et al. 2012 ) and dysregulation of plasma lipoproteins, including low-density lipoproteins (LDL) and high-density lipoproteins (HDL), has been directly linked to diabetes, obesity and metabolic disease in general (Chan et al. 2004) .
In summary, our data show that As3mt KO in mice resulted in an adverse phenotype that was characterized primarily by obesity and insulin resistance. However, insulin resistance was much more pronounced in male KO as compared to female KO mice. The exposure to 0.1 and 1 ppm As (as arsenite) in drinking water further exacerbated this phenotype in both male and female KO mice, but the effects were not always statistically significant. The background exposure to relatively high levels of iAs in the diet or effects of As3mt KO on expression of metabolic genes may be responsible for the differences in the metabolic phenotypes of WT and KO mice and/or for the relatively minor responses to the additional exposure to iAs from drinking water. The mechanisms by which As3mt KO alters metabolic phenotype in a sex-dependent manner in the absence or presence of iAs exposure are unclear and should be investigated in future studies. These studies should control for As levels in laboratory diet and should examine effects of iAs exposure in the glucose utilizing tissues and in the pancreas, including effects of As3mt KO on expression of genes regulating major metabolic pathways and energy metabolism.
